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ORIGINAL ARTICLE BACTERIOLOGYState-wide surveillance of antibiotic resistance patterns and spa types of
methicillin-resistant Staphylococcus aureus from blood cultures in North
Rhine-Westphalia, 2011–2013C. Cuny1, F. Layer1, G. Werner1, D. Harmsen2, I. Daniels-Haardt3, A. Jurke3, A. Mellmann4, W. Witte1 and R. Köck4,5
1) Robert Koch-Institute, National Reference Laboratory for Staphylococci and Enterococci, Wernigerode, 2) Department of Periodontology, University Hospital
Münster, 3) Centre for Health North Rhine-Westphalia, 4) Institute of Hygiene and 5) Institute of Medical Microbiology, University Hospital Münster, Münster,
GermanyAbstractMethicillin-resistant Staphylococcus aureus (MRSA) is a major cause of bacteraemia. We aimed to obtain a complete picture of severe MRSA
infections by characterizing all MRSA isolates from bloodstream infections in the largest German federal state (North Rhine-Westphalia, 18
million inhabitants) using S. aureus protein A (spa) sequence-typing and antimicrobial susceptibility testing. MRSA isolates (n = 1952) were
collected prospectively (2011–2013) and spa-typed. Among 181 different spa types, t003 (n = 746 isolates; 38.2%) and t032 (n = 594;
30.4%) were predominant. Analysis of the geographical occurrence of spa clonal complexes (spa-CCs) and spa types revealed divergent
distribution between federal state districts for spa-CCs 003 (p < 0.001; including t003, p < 0.001 and t264, p < 0.001), 008 (p 0.021),
011 (p 0.002), 032 (p < 0.001; including t022, p 0.014 and t032, p < 0.001) and spa type t2807 (p < 0.001). MICs of antimicrobial
substances were tested using broth microdilution. Of all isolates, 96% were resistant to ﬂuoroquinolones, 78% to erythromycin, 70% to
clindamycin, 4% to gentamicin, 2% to rifampicin, 0.4% to daptomycin, 0.1% to linezolid and 0% to vancomycin, respectively. Vancomycin
MICs of 2 mg/L involved 0.5% of the isolates. In conclusion, the detection of regional molecular clusters added valuable information for
epidemiological case tracing and allowed conclusions to be reached on the importance of newly emerging MRSA reservoirs, such as
livestock (spa-CC011), for MRSA bacteraemia in some parts of the federal state. Susceptibility testing revealed broad resistance to
substances used for oral treatment, but demonstrated that those antibiotics that are mostly applied for treatment of MRSA bacteraemia
and important combination partners were highly susceptible.
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rights reserved.
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associated infections involved 5.7% of patients in Europe [1].Microbiol Infect 2015; 21: 750–757
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.02.013Staphylococcus aureus was the second most frequent organism,
causing 12.3% of these infections with 41.2% of all isolates being
methicillin-resistant (MRSA) [1]. Although the percentage of
S. aureus isolates from blood cultures reported as MRSA has
recently stabilized, MRSA causes an estimated >5000 excess
deaths and >250 000 excess hospital days annually in European
countries [2], which shows that MRSA prevention and avail-
ability of effective therapeutic options are still public health
priorities.
An investigation assessing the clonal structure of S. aureus
from cases of invasive infections using S. aureus protein A (spa)ious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Cuny et al. spa types and antimicrobial resistance of MRSA 751typing demonstrated the presence of few predominant MRSA
spa types and suggested selection and spread of a limited
number of clones leading to regional clusters [3]. As studies
found that such regional emergence of MRSA was fuelled by
patient movements between different cooperating healthcare
facilities [4], data on molecular characteristics of MRSA can add
valuable information to conventional surveillance data (time,
place, person) and can support the work of local infection
control staff or public health authorities. This is also important,
because in some countries new reservoirs for MRSA infections
outside healthcare facilities (community-associated or livestock-
associated cases) have recently gained greater impact [5].
Appropriate empirical antibiotic therapy of MRSA bacter-
aemia is essential for reduction of mortality [6]. Surveillance
data on resistance phenotypes of MRSA can indicate effective
therapeutic options and allow for early recognition of the
emergence of MRSA harbouring new antibiotic resistance traits
[7]. As the number of patients in hospitals with MRSA bac-
teraemia correlates with the number of all patients affected by
an MRSA infection [8], mandatory notiﬁcation of MRSA bac-
teraemia cases to regional health authorities is an important
MRSA surveillance tool. Although a mandatory notiﬁcation
system for the detection of MRSA from blood cultures was
established in Germany in 2009, there is currently no system
for mandatory collection of MRSA isolates for the purpose of
country-wide investigation of molecular types or clinically
relevant antimicrobial resistance.
To address these issues, we performed this prospective
characterization of MRSA isolates derived from blood cultures
obtained from patients in the most populated German federal
state during a 23-month period. All isolates were characterized
using spa typing and antimicrobial resistance testing based on
broth microdilution.MethodsThis study was carried out in the German federal state of North
Rhine-Westphalia (NRW; 17.6 million inhabitants, i.e. 22% of
the total German population; 370 hospitals, 120 247 hospital
beds in 2013). Hospitals and microbiology laboratories were
asked to voluntarily send every ﬁrst MRSA isolate from blood
cultures of each patient obtained between December 2011 and
October 2013 to a central typing facility at the Institute of
Hygiene, University Hospital Münster, together with anony-
mized information on the patient’s age and sex. To yield
geographical information, laboratories were asked to which
local public health authority (on district level) the MRSA bac-
teraemia case was notiﬁed. Notiﬁcation has to be made to the
local health authority in the district where the patient ofﬁciallyClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyresides or where the patient has his current location (e.g.
hospital). All notiﬁcations are documented in a central database
(http://www3.rki.de/SurvStat/). Geographical information was
assessed using the Nomenclature of Units for Territorial Sta-
tistics deﬁned by the European Commission.
Typing of isolates
All bacterial isolates were characterized by spa sequence-based
typing as described previously [9] using primers spa_1113f (50-
TAA AGA CGA TCC TTC GGT GAG C-30) and spa_1514r
(50-CAG CAG TAG TGC CGT TTG CTT-30) or alternative
primers spa_239f, spa_1717r [10]. For clustering of spa types
and grouping in spa-clonal complexes (spa-CC) we used the
Based Upon Repeat Pattern (BURP) algorithm of the Staph-
Type™ software (Ridom GmbH, Münster, Germany) with
default parameters as recommended previously [11]. Multilocus
sequence typing (MLST) was performed for spa non-typeable
isolates, isolates grouped as singletons and for those excluded
from clustering in the BURP analysis [12]. For the other iso-
lates, the MLST clonal complexes (CC) corresponding to the
respective spa-CCs were assessed from the SpaServer website
(www.spaserver.ridom.de), as it was demonstrated that there is
a high concordance between BURP and MLST-based clustering
results [13]. Statistical differences in the occurrence of spa
types were calculated using chi-squared test or Fisher’s exact
test (IBM SPSS Statistics, version 22). P-values <0.05 were
considered to be signiﬁcant.
Antimicrobial susceptibility testing
All isolates were subjected to antimicrobial susceptibility testing
using broth microdilution according to EUCAST guidelines and
clinical breakpoints (version 4.0; www.eucast.org) at the Robert
Koch-Institute, National Reference Centre for staphylococci
and enterococci, Wernigerode branch, Germany. The MICs
were determined for 17 substances from 15 antibiotic classes. If
isolates were susceptible to oxacillin, they were excluded from
the study. PCR for cfr, a mobile genetic element conferring
linezolid resistance, was performed as described previously
[14].ResultsTyping of isolates
Overall, 1952 MRSA isolates from 57 microbiological labora-
tories in NRW were spa typed. In 11 cases, two different iso-
lates (with respect to susceptibility proﬁles and spa types) were
collected from the same blood culture specimen (i.e. the 1952
isolates were obtained from 1941 different patients). The iso-
lates were notiﬁed to authorities in 53 of the 55 districts ofand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 750–757
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DEA45 (Fig. 1). Varying numbers of isolates typed per district
can partly be explained by the divergent number of hospital
beds (Fig. 1; see Supporting information, Table S1). Ofﬁcial
notiﬁcation records indicate that during the study period, 2741
cases of MRSA bacteraemia occurred (data from http://www3.
rki.de/SurvStat/; date of retrieval 23 November 2013). Hence,
MRSA isolates for 71% of these cases were collected and spa
typed. Among the 1941 patients, the median age was 74 years
(mean 71.8 years; range 0–100 years) and 61.7% were male.
A total of 181 spa types were identiﬁed. Two spa types, t003
and t032, were predominant and represented 746 (38.2%) and
594 (30.4%) isolates, respectively. They were followed by t022
(n = 55; 2.8%), t264 (n = 37; 1.9%), t045 (n = 35; 1.8%), t020
(n = 24; 1.2%), t008 (n = 22; 1.1%), t002 (n = 19; 1.0%), t034
(n = 16; 0.8%), t014 (n = 15; 0.8%) and t011 (n = 15; 0.8%).
Table 1 shows the distribution of spa types in different spa-CCs
and the corresponding MLST CCs. Only one MRSA isolate
(0.05%), characterized by MLST sequence type (ST) 22 was not
spa typeable even when using alternative primer sets.
Analysis of the spatial distribution of spa types demonstrated
signiﬁcant divergence between districts of the federal state (spa
type in the respective district versus all other districts) for spaClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecttypes t003 (range 6.25–100%of all isolates in a district; p < 0.001),
t022 (range 0–13%; p 0.014), t032 (range 0–77%; p < 0.001), t264
(range 0–12%; p < 0.001) and t2807 (range 0–47%; p < 0.001).
On the level of spa-CCs signiﬁcant divergence was found for spa-
CCs 003 (p < 0.001), 008 (p 0.021), 011 (p 0.002), 032 (p < 0.001)
and singletons (p < 0.001) (see Supporting information, Table S1).
Within spa-CC011, isolates belonging to the MLST CC398 clonal
lineage (t011, t034, t1451), indicative for livestock-associated
MRSA, represented 1.7% of the bacteraemia isolates. Regional
clusterswere found in those areas of NRWthat are characterized
by a high density of pig production (Fig. 2).
Antimicrobial susceptibility testing
All 1952 isolates were conﬁrmed to be MRSA. Table 2 shows
the proportions of resistance to other antibiotics among iso-
lates belonging to different MRSA clonal lineages. Of all isolates
tested, 0.4% (n = 7) and 0.1% (n = 1) were resistant to dap-
tomycin and linezolid, respectively. Daptomycin-resistant iso-
lates had an MIC of 2 mg/L, were attributed to spa types t022
(n = 1), t032 (n = 2) and t432 (n = 1) (all MLST CC22), as well
as t003 (n = 2) and t463 (n = 1) (both CC5) and were derived
from six different districts. The majority of isolates (93.3%) had
daptomycin MICs of 0.5 mg/L.FIG. 1. Origin of methicillin-
resistant Staphylococcus aureus
(MRSA) isolates from cases of bac-
teraemia in North Rhine-Westphalia
(2011–2013). Colours indicate the
number of hospital beds per district.
The number of isolates typed from
the respective districts is indicated by
the edge around the district code.
Districts within the German federal
state of North Rhine-Westphalia are
designated according to the
Nomenclature of Units for Territo-
rial Statistics (NUTS) code ‘DEA’.
From districts DEA 44 and 45,
no MRSA isolates were typed. Map:
©d-maps.com; http://d-maps.com/
carte.php?num_car=24031&lang=de.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 750–757
TABLE 1. Distribution of spa types, spa-clonal complexes and associated multilocus sequence types (MLST) and clonal complexes
(CC) in methicillin-resistant Staphylococcus aureus (MRSA) isolates from blood cultures in North Rhine-Westphalia
spa CCa spa-types (no. of isolates) MLSTb
C003 (n = 929, 48%) t001 (1), t002 (19), t003 (746), t010 (2), t014 (15), t035 (5), t041 (3), t045 (35), t067 (5), t10231 (1), t10261 (1),
t10461 (1), t105 (1), t1079 (1), t10882 (2), t11646 (1), t11679 (1), t12331 (1), t1303 (1), t151 (4), t1947 (1),
t2007 (2), t214 (1), t2146 (1), t264 (37), t422 (4), t447 (1), t4591 (2), t481 (4), t504 (2), t539 (1), t548 (1), t564
(1), t5655 (2), t579 (1), t603 (2), t626 (6), t627 (2), t6860 (4), t7563 (1), t837 (1), t8799 (2), t893 (2), t9935 (2)
CC5
CC032 (n = 834, 43%) t005 (2), t016 (1), t020 (24), t022 (55), t025 (12), t032 (594), t10015 (1), t10016 (1), t10023 (1), t10027 (1), t10159
(1), t1036 (1), t1068 (1), t11350 (1), t11522 (1), t1157 (1), t11710 (3), t11824 (1), t12066 (1), t1214 (4), t12224
(1), t1249 (1), t1275 (2), t1279 (1), t12996 (1), t1302 (1), t1332 (1), t1370 (3), t1378 (1), t1390 (1), t1499 (2),
t1770 (2), t223 (1), t2369 (4), t2377 (1), t294 (3), t3139 (5), t3212 (3), t3490 (3), t3555 (1), t3612 (1), t379 (13),
t4081 (2), t4217 (1), t4292 (2), t431 (1), t432 (3), t4623 (1), t474 (1), t4892 (1), t5347 (1), t541 (1), t557 (2), t578
(2), t5857 (1), t5888 (1), t608 (8), t612 (1), t625 (1), t628 (2), t651 (1), t6730 (2), t683 (1), t712 (2), t717 (6), t718
(8), t747 (1), t749 (14), t8221 (1), t8586 (1), t8701 (1), t9497 (1), t9502 (1), t9570 (1), t965 (2)
CC22
CC011 (n = 45, 2%) t011 (15), t034 (16), t10727 (1), t1255 (1), t1451 (1), t2576 (1) CC398
t037 (4), t685 (1), t012 (2), t018 (1), t030 (2) CC30
CC038 (n = 21, 1%) t015 (2), t038 (10), t10447 (1), t2149 (1), t2265 (1), t331 (1), t691 (1), t739 (2), t740 (2) CC45
CC008 (n = 30, 2%) t008 (22), t024 (3), t064 (1), t068 (1), t121 (1), t304 (1), t681 (1) CC8
C004 (n = 15, 2%) t004 (9), t040 (2), t065 (3), t266 (1) CC45
CC359 (n = 7, 0.4%) t044 (3), t267 (1), t359 (3) CC80
excluded (n = 41, 2%) t026 (1) ST45*
t027 (1) ST225*
t12120 (1) ST225*
t1304 (1) ST22*
t1372 (1) ST22*
t1977 (2) ST22*
t2006 (2) ST22*
t2207 (1) ST1*
t2261 (3) ST45*
t2302 (1) ST5*
t3477 (3) ST22*
t362 (2) ST45*
t386 (1) ST1*
t458 (3) ST225*
t463 (5) ST225*
t535 (7) ST225*
t586 (3) ST225*
t693 (1) ST1*
t777 (1) ST5*
t9900 (1) ST225*
singletons (n = 29, 1%) t10418 (1) ST22*
t11929 (1) ST22*
t127 (10) ST1*
t136 (1) ST34*
t1430 (3) ST9*
t2807 (11) ST22*
t5047 (1) ST152*
t9464 (1) ST2616*
NT NT ST22*
aspa-CC = spa clonal complex as determined by Based Upon repeat Pattern (BURP) algorithm, ‘excluded’ from BURP clustering because the spa repeat pattern comprised fewer
than ﬁve repeats.
bInformation on clonal complex (CC) or sequence type (ST) as deﬁned by multilocus sequence typing (MLST); for isolates indicated by *, MLST was performed for one isolate per spa
type in this study, for the remaining isolates MLST CC is shown as this information is provided on the SpaServer website (www.spaserver.ridom.de), NT = spa non-typeable.
CMI Cuny et al. spa types and antimicrobial resistance of MRSA 753The only linezolid-resistant isolate (MIC 8 mg/L; spa type
t003) did not contain cfr; 97% of the isolates had an MIC of
2 mg/L for linezolid.
None of the MRSA isolates tested was resistant to vanco-
mycin (MIC > 2 mg/l) and only 10 isolates (0.5%) exhibited
vancomycin MICs close to the breakpoint (i.e. had an MIC of
2 mg/L); the MIC for the remaining isolates was 1 mg/L. Five of
the ten isolates with MIC of 2 mg/L were resistant to dapto-
mycin as well. The spa types and geographical origin of these
isolates were as follows: four isolates with t003 (districts
DEA44, 45, 47, 50); four isolates with t032 (DEA33, 40, 44, 45),
one isolate t065 (DEA47) and one isolate t041 (DEA42).
Tigecycline was resistant in 0.2% with resistant isolates
(n = 4) being associated with spa types t037 (n = 2, DEA75) and
t045 (n = 2, DEA20, 40).
Of all 1952 isolates, 1.2% were susceptible to all antibiotics
tested except β-lactams. The predominant combination ofClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyresistance patterns (found in more than 1% of all isolates) are
shown in the Supporting information (Fig. S1). None of the
isolates tested in this study fulﬁlled recent deﬁnitions for
extensively drug-resistant and pandrug-resistant S. aureus iso-
lates [15]. Isolates exhibiting the most resistant phenotypes
involving seven or more of the 15 tested antibiotic classes are
shown in the Supporting information (Table S2).DiscussionA cross-border comparative investigation recently showed that
the annual incidence of MRSA bacteraemia in the German
federal state of NRW was 57.6/1 000 000 inhabitants, which is
32 times higher than in the Dutch neighbouring region [16].
This demonstrates that although the proportion of MRSA
among all S. aureus isolates obtained from blood cultures hasand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 750–757
FIG. 2. Proportion of CC398 among
methicillin-resistant Staphylococcus
aureus (MRSA) from blood cultures
in North Rhine-Westphalia
(2011–2013). Colours indicate the
proportion of MRSA CC398 on all
MRSA isolates typed from the
respective districts. Districts within
the German federal state of North
Rhine-Westphalia are designated ac-
cording to the Nomenclature of
Units for Territorial Statistics
(NUTS) code ‘DEA’. From districts
DEA 44 and 45, no MRSA isolates
were typed. Pig densities in the dis-
tricts are indicated according to data
from Statistisches Bundesamt, https://
www.destatis.de/. Map: ©d-maps.
com; http://d-maps.com/carte.php?
num_car=24031&lang=de.
TABLE 2. Antimicrobial resistances (%) among 1952 methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates
associated with different clonal lineages
spa-CC* 003 004 008 011 032 038 359 Excluded NT Singleton
Total %MLST CC 5 45 8 398 030 22 45 80 div. 22 div.
GEN 4.1 6.7 10.0 11.4 60.0 1.4 0.0 28.6 2.4 0.0 3.4 3.5
ERY 96.0 26.7 76.7 48.6 80.0 63.4 4.8 0.0 73.2 100 44.8 77.8
CLI 81.9 26.7 73.3 51.4 70.0 62.2 4.8 0.0 65.9 100 13.8 69.9
FUS 1.7 6.7 6.7 0.0 0.0 0.6 0.0 42.9 2.4 0.0 0.0 1.4
TET 1.2 13.3 3.3 100.0 60.0 0.2 9.5 28.6 7.3 0.0 34.5 3.8
SXT 0.0 0.0 3.3 5.7 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2
CIP 98.1 100 96.7 20.0 70.0 99.2 85.7 14.3 87.8 100 65.5 95.9
MFL 98.4 100 96.7 25.7 60.0 99.2 85.7 0.0 87.8 100 55.2 95.9
MUP 5.3 0.0 10.0 2.9 10.0 3.5 0.0 0.0 2.4 0.0 0.0 4.3
RIF 1.7 0.0 3.3 0.0 50.0 1.9 0.0 0.0 2.4 0.0 0.0 2.0
FOS 0.8 0.0 6.7 0.0 40.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0
TGC 0.1 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2
DAP 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.4
LNZ 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
Total no. 929 15 30 35 10 834 21 7 41 1 29 1,952
Data are shown for all isolates and stratiﬁed for isolates associated with different spa clonal complexes (spa-CC) or clonal complexes (CC) or sequence types (ST) as deﬁned by
multilocus sequence typing (MLST). ‘Excluded’ from Based Upon Repeat Pattern (BURP) clustering because the spa repeat pattern comprised fewer than ﬁve repeats; ‘div.’ indicates
diverse MLST CCs and STs among isolates excluded from BURP clustering and singletons.
Data indicate the percentage (%) of resistance for each respective antibiotic: GEN (gentamicin), ERY (erythromycin), CLI (clindamycin), FUS (fusidic acid), TET (tetracycline), SXT
(cotrimoxazole), CIP (ciproﬂoxacin), MFL (moxiﬂoxacin), MUP (mupirocin; given in “I+R”), RIF (rifampicin), FOS (fosfomycin), TGC (tigecycline), DAP (daptomycin), LNZ
(linezolid). Vancomycin resistance was not detected. All isolates were resistant to penicillin and oxacillin. The last line indicates the total number of isolates tested within each spa-
CC.
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CMI Cuny et al. spa types and antimicrobial resistance of MRSA 755decreased in Germany in the past couple of years [1], pre-
ventive efforts are still warranted. Such efforts can be suc-
cessful, as shown in England, where the implementation of care-
bundles and mandatory surveillance led to a decrease of MRSA
bacteraemia rates from 78 per 1 0000 000 of the population
(2006/2007) to 13 per 1 000 000 of the population in 2014
(second quarter) [17,18].
This study represents the ﬁrst assessment of molecular
typing data and MIC-based susceptibility testing for
bacteraemia-associated MRSA isolates in Germany, which can
be considered as representative for the most populated
German federal state. Other studies from Germany published
until now either comprised a small number of bacteraemia
isolates only or rather reﬂected local situations [3,7]. Although,
MRSA isolates were voluntarily forwarded to the typing facility,
we received samples from 71% of all MRSA bacteraemia cases
notiﬁed to public health authorities during the study period and
achieved a good spatial coverage. In addition, representative-
ness of the data can be concluded from the fact that basic
epidemiological parameters of the patients included (61.7%
male, median age 74 years) are almost identical to ofﬁcial data
from the mandatory notiﬁcation system (61% male, median age
73 years) [16].
We identiﬁed signiﬁcantly divergent distributions of several
spa-CCs and single spa types in the districts of NRW, which
indicates regional dissemination. For example, nine of the
eleven cases of spa type t2807 were detected in district DEA38
(and the other two in DEA2D and DEA42; data not shown).
Hence, the spatial cluster of t2807 in DEA38 could either
indicate distinct spread in healthcare facilities in this district
respecting regional borders or a local outbreak of MRSA in-
fections. In this context, it is a clear limitation of this study that
we did not have access to classical epidemiological information
allowing for correlation with the typing data. However, for
public health authorities and clinicians, where this epidemio-
logical information is available, the typing data assessed could
guide outbreak investigations and facilitate unravelling trans-
mission pathways. This example supports that spa sequence-
based typing can be implemented as a baseline tool for mo-
lecular surveillance and outbreak detection.
Signiﬁcant regional variation was also found for MRSA within
spa-CC011 (e.g. spa types t011, t034), which are associated
with MLST CC398. Although this MRSA clonal lineage
accounted for 1.7% of all MRSA in the federal state, this pro-
portion was much higher in the northern districts (Fig. 2).
Older studies demonstrated that MRSA CC398 represents an
increasing proportion of MRSA isolates in different European
countries [3,19]. This ﬁnding was alarming, because a close
relationship was identiﬁed between the occurrence of MRSA
CC398 as a cause of human infections and the regional densityClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyof pig and cattle production [19]. This strongly suggested that
these MRSA are transmitted from livestock animals, where
MRSA CC398 is widely disseminated [20]. In contrast to pre-
vious German investigations [21,22], this study represents the
ﬁrst representative investigation of this question for a complete
federal state comprising urban and rural areas. Our results
support that MRSA CC398 is still predominant in livestock-
dense regions and is not efﬁciently transmitted to urban
areas. Tetracycline resistance was a sensitive (phenotypic) in-
dicator for MRSA CC398, but tetracycline resistance occurred
in other clonal lineages as well. The positive predictive value for
predicting the clonal lineage from tetracycline resistance was
only 47% (MRSA CC398 35/35 versus non-CC398 39/1878;
data not shown).
The MIC data of all MRSA bacteraemia isolates revealed the
highest resistance (96%) for ﬂuoroquinolones. This limits the
use of this drug, particularly for treating bone or prosthetic
joint infections, which are a relevant source for MRSA bac-
teraemia and often warrant prolonged oral treatment [23,24].
Alternatives for oral treatment in these cases can be cotri-
moxazole or linezolid. The MRSA isolates tested were usually
susceptible to gentamicin and tetracycline, two compounds for
which much higher rates of resistance were observed histori-
cally. The decreasing trend in antimicrobial resistance of MRSA
for these substances is currently observed in many countries
worldwide associated with less frequent occurrence of older
broadly resistant epidemic healthcare-associated MRSA clonal
lineages [25,26]. Broader resistance involving seven or more
antibiotic classes (see Supporting information, Table S2) was
mainly (6 of 13 cases) associated with MRSA of spa types t030
and t037, both exhibiting MLST ST239 [27]. This clone, which
accounted for <1% of the isolates in this study, has been rarely
found in Germany and the cases observed in this study might
have been imported [7].
Importantly, all antibiotics currently used for baseline ther-
apy of bacteraemic MRSA infections, such as vancomycin,
daptomycin or linezolid, were susceptible in >99%. As for these
substances, stepwise acquisition of genetic mutations can lead
to clinical ineffectiveness, it is important to monitor their MIC
distributions with a focus on isolates near the clinical break-
points [28–30]. Among clinical S. aureus isolates that are
categorized as susceptible to vancomycin (2 mg/L), a trend
towards reduced vancomycin susceptibility, i.e. increasing MICs
(‘vancomycin MIC creep’) was recently observed in some
centres worldwide, which was partially associated with worse
clinical outcome [31]. In this study, only 0.5% of the MRSA
isolates had vancomycin MICs of 2 mg/L, as determined by
broth microdilution. However, it should be kept in mind that
MIC creep can be lost after storage and sub-cultivation of the
isolate [32]. Reduced susceptibility to vancomycin can also beand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 750–757
756 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMIassociated with daptomycin resistance [33], most probably as
the result of mutations in particular regulatory genes affecting
cell wall synthesis [28]. Indeed, ﬁve of ten isolates with van-
comycin MICs of 2 mg/L were daptomycin resistant.
In conclusion, we found a regionally divergent distribution of
MRSA clonal lineages in the most-populated German federal
state with geographically distinct occurrence of single spa types
and livestock-associated clones. Antimicrobial resistance of
those substances that are mainly used to treat MRSA bacter-
aemia was <1%, but we found signiﬁcant clinically relevant
problems associated with ﬁnding therapeutic options for the
therapy of severe infections (e.g. bone infections) needing
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